Tobii Dynavox will evaluate Control Bionics’ (ASX:CBL) NeuroNode for a six-month pilot period in five US states Control Bionics said NeuroNode replaces a previous Tobii Dynavox partner in the US and ...
Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...
Control Bionics secures deal with Tobii Dynavox, global leader with augmentative and alternative communication solutions to evaluate its NeuroNode technology. Tobii Dynavox will evaluate Control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results